Atlas Molecular Pharma to Begin Dosing First Patients in Phase 2 Trial of ATL-001 for Cong... 03/09/2026 Healthcare Rare diseases Innovative drugs Atlas Molecular Pharma, a Basque biotech developing pharmacological chaperone therapies for rare diseases, announces... Partners - Atlas Molecular Pharma
Batea Oncology and dsm-firmenich Partner to Support Clinical Development of GlioHook® for ... 02/09/2026 Healthcare Innovative drugs Advanced therapies Batea Oncology and dsm-firmenich are building on a longstanding collaboration dedicated to advancing GlioHook®, an... Partners - BATEA ONCOLOGY S.L.
ORYZON announces Notice of Allowance for U.S. patent application covering iadademstat com... 31/08/2026 Healthcare Drug discovery Innovative drugs Iadademstat is under clinical development in acute myeloid leukemia (AML), including in combination with gilteritinib in... Partners - Oryzon Genomics
Almirall and Certest Biotec enter strategic research collaboration and licensing agreement 31/08/2026 Healthcare Rare diseases Innovative drugs Almirall and Certest Biotec, S.L., through its pharmaceutical division, Certest Pharma, have entered into a strategic... Partners - CERTEST BIOTEC
Regulatory Shifts Ahead: Preparing for FDA Changes and EU Pharmaceutical Reform Online Del 16/09/2026 to 16/09/2026 Healthcare Access to innovation Innovative drugs
Accelerating Pre-Clinical Large-Molecule Screening with an Integrated DMPK/ADME Approach Online Del 02/09/2026 to 02/09/2026 Healthcare Innovative drugs Advanced therapies
Celtarys Research expands into Targeted Protein Degradation with new tools for PROTAC and ... 28/08/2026 Healthcare Drug discovery Innovative drugs Celtarys Research has expanded its drug discovery portfolio into Targeted Protein Degradation (TPD), launching new... Partners - Celtarys Research
Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 Phase 2a Clinical Trial to Eva... 21/08/2026 Healthcare Innovative drugs Advanced therapies VIRAGE2 exploratory study designed to refine the VCN-01 dosing regimen for potential evaluation in a future pivotal... Partners - THERIVA BIOLOGICS S.L.
Riyadh Global Medical Biotechnology Summit (RGMBS) 2026 Riyadh Kingdom of Saudi Arabia Del 14/09/2026 to 16/09/2026 Healthcare Access to innovation Innovative drugs International
CriteriaCaixa reboosts its investment business in science and technology -based startups 17/07/2026 Healthcare Innovative drugs Financing Caixa Capital Risc, a CriteriaCaixa venture capital management company, rebrands to Criteria Capital Risc. Partners - CRITERIA BIO VENTURES
